HEADER HYDROLASE/HYDROLASE INHIBITOR 31-JAN-03 1NU7 TITLE STAPHYLOCOAGULASE-THROMBIN COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: THROMBIN LIGHT CHAIN; COMPND 3 CHAIN: A, E; COMPND 4 FRAGMENT: UNP RESIDUES 332-359; COMPND 5 SYNONYM: COAGULATION FACTOR II; COMPND 6 EC: 3.4.21.5; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: THROMBIN HEAVY CHAIN; COMPND 9 CHAIN: B, F; COMPND 10 FRAGMENT: UNP RESIDUES 364-622; COMPND 11 SYNONYM: COAGULATION FACTOR II; COMPND 12 EC: 3.4.21.5; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: STAPHYLOCOAGULASE; COMPND 15 CHAIN: D, H; COMPND 16 FRAGMENT: UNP RESIDUES 1-281; COMPND 17 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: BLOOD; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 TISSUE: BLOOD; SOURCE 11 MOL_ID: 3; SOURCE 12 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS; SOURCE 13 ORGANISM_TAXID: 1280; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PET30A KEYWDS THROMBIN NON-PROTEOLYTIC ACTIVATOR, HYDROLASE-HYDROLASE INHIBITOR KEYWDS 2 COMPLEX, PROTEIN BINDING EXPDTA X-RAY DIFFRACTION AUTHOR R.FRIEDRICH,W.BODE,P.FUENTES-PRIOR,P.PANIZZI,P.E.BOCK REVDAT 4 13-JUL-11 1NU7 1 VERSN REVDAT 3 24-FEB-09 1NU7 1 VERSN REVDAT 2 21-OCT-03 1NU7 1 SEQRES REVDAT 1 07-OCT-03 1NU7 0 JRNL AUTH R.FRIEDRICH,P.PANIZZI,P.FUENTES-PRIOR,K.RICHTER,I.VERHAMME, JRNL AUTH 2 P.J.ANDERSON,S.KAWABATA,R.HUBER,W.BODE,P.E.BOCK JRNL TITL STAPHYLOCOAGULASE IS A PROTOTYPE FOR THE MECHANISM OF JRNL TITL 2 COFACTOR-INDUCED ZYMOGEN ACTIVATION JRNL REF NATURE V. 425 535 2003 JRNL REFN ISSN 0028-0836 JRNL PMID 14523451 JRNL DOI 10.1038/NATURE01962 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 418329.760 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.6 REMARK 3 NUMBER OF REFLECTIONS : 90671 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4565 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 13844 REMARK 3 BIN R VALUE (WORKING SET) : 0.2980 REMARK 3 BIN FREE R VALUE : 0.3370 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 709 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.013 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9310 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 102 REMARK 3 SOLVENT ATOMS : 748 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 12.64000 REMARK 3 B22 (A**2) : -10.21000 REMARK 3 B33 (A**2) : -2.43000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 11.13000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.30 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.34 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.33 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.60 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.01 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.360 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.160 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.260 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.300 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 43.91 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : P43.PARAM REMARK 3 PARAMETER FILE 4 : ARM.PARAM REMARK 3 PARAMETER FILE 5 : ION.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : P43.TOP REMARK 3 TOPOLOGY FILE 4 : ARM.TOP REMARK 3 TOPOLOGY FILE 5 : ION.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1NU7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 17-FEB-03. REMARK 100 THE RCSB ID CODE IS RCSB018209. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-MAY-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MPG/DESY, HAMBURG REMARK 200 BEAMLINE : BW6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0085, 1.0050, 0.9200 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 90671 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM IMIDAZOLE, 200MM SODIUM FORMATE, REMARK 280 12%(W/V) PEG 4000, PH 7.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 90.08500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 90.08500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 51.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6560 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27540 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -61.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6560 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -62.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU B 247 REMARK 465 GLY E 1D REMARK 465 GLU F 247 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 MET D 0 REMARK 475 ILE D 1 REMARK 475 VAL D 2 REMARK 475 THR D 3 REMARK 475 LYS D 4 REMARK 475 MET H 0 REMARK 475 ILE H 1 REMARK 475 VAL H 2 REMARK 475 THR H 3 REMARK 475 LYS H 4 REMARK 475 ASP H 5 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 14D CG CD NE CZ NH1 NH2 REMARK 480 LEU A 14G CD1 CD2 REMARK 480 ASP B 60E CG OD1 OD2 REMARK 480 LYS B 109 CE NZ REMARK 480 LYS B 186D CD CE NZ REMARK 480 PHE B 204A CD1 CD2 CE1 CE2 CZ REMARK 480 ASP D 5 N REMARK 480 LYS D 8 CG CD CE NZ REMARK 480 GLU D 14 OE2 REMARK 480 GLU D 93 CD OE1 OE2 REMARK 480 LYS D 99 CE NZ REMARK 480 LYS D 101 CD CE NZ REMARK 480 LYS D 126 CE NZ REMARK 480 LYS D 130 CD CE NZ REMARK 480 LYS D 134 CG CD CE NZ REMARK 480 HIS D 144 CG ND1 CD2 CE1 NE2 REMARK 480 LYS D 147 CD CE NZ REMARK 480 GLU D 199 OE1 OE2 REMARK 480 LYS D 212 CD CE NZ REMARK 480 GLU D 219 OE1 REMARK 480 TYR D 247 CE1 CE2 CZ OH REMARK 480 SER D 251 OG REMARK 480 LYS D 279 CD CE NZ REMARK 480 ARG E 14D CD NE CZ NH1 NH2 REMARK 480 LEU E 14G CD1 CD2 REMARK 480 ASP F 60E OD1 OD2 REMARK 480 LYS F 109 CE NZ REMARK 480 GLU F 127 CD OE1 OE2 REMARK 480 LYS F 149E CE NZ REMARK 480 LYS F 186D CE NZ REMARK 480 GLU F 192 OE1 REMARK 480 PHE F 204A CD1 CD2 CE1 CE2 CZ REMARK 480 GLN F 244 OE1 NE2 REMARK 480 LYS H 8 CB CG CD CE NZ REMARK 480 GLU H 14 OE1 REMARK 480 GLU H 75 OE2 REMARK 480 LYS H 90 CE NZ REMARK 480 LYS H 99 CE NZ REMARK 480 LYS H 101 CE NZ REMARK 480 ARG H 116 NH2 REMARK 480 LYS H 130 CD CE NZ REMARK 480 LYS H 134 CD CE NZ REMARK 480 GLU H 137 CD OE1 OE2 REMARK 480 LYS H 156 CE NZ REMARK 480 THR H 179 CG2 REMARK 480 GLU H 199 OE2 REMARK 480 LYS H 212 NZ REMARK 480 TYR H 247 CE1 CE2 CZ OH REMARK 480 LYS H 248 CD CE NZ REMARK 480 GLU H 252 CD OE1 OE2 REMARK 480 LYS H 279 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER B 195 O3 0ZJ B 299 1.82 REMARK 500 OG SER F 195 O3 0ZJ F 299 1.85 REMARK 500 OG SER B 195 CM 0ZJ B 299 2.05 REMARK 500 OG SER F 195 CM 0ZJ F 299 2.06 REMARK 500 O HOH B 403 O HOH B 404 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 VAL D 2 N - CA - C ANGL. DEV. = 17.3 DEGREES REMARK 500 ARG D 209 NE - CZ - NH1 ANGL. DEV. = -3.3 DEGREES REMARK 500 ARG H 209 NE - CZ - NH1 ANGL. DEV. = -3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 7 -92.56 -125.53 REMARK 500 TYR B 60A 82.33 -157.31 REMARK 500 ASN B 60G 80.19 -163.76 REMARK 500 HIS B 71 -61.38 -121.70 REMARK 500 ASN B 98 23.05 -151.28 REMARK 500 ASP B 186A 37.20 -95.38 REMARK 500 SER B 195 135.16 -39.01 REMARK 500 ILE D 1 18.38 -69.91 REMARK 500 VAL D 2 -29.31 105.28 REMARK 500 THR D 3 117.71 61.23 REMARK 500 LYS D 4 -65.68 -100.00 REMARK 500 LYS D 201 64.60 -157.54 REMARK 500 HIS D 250 57.36 -141.66 REMARK 500 PHE E 7 -87.10 -127.95 REMARK 500 TYR F 60A 84.83 -156.85 REMARK 500 ASN F 60G 75.96 -166.45 REMARK 500 ARG F 77A -61.97 -28.65 REMARK 500 GLU F 97A -54.42 -121.78 REMARK 500 ASN F 98 19.19 -151.15 REMARK 500 SER F 214 -56.22 -120.99 REMARK 500 TYR H 6 -160.58 -75.27 REMARK 500 LYS H 201 67.59 -162.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 VAL D 2 22.1 L L OUTSIDE RANGE REMARK 500 LYS E 14A 24.6 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH H2084 DISTANCE = 6.10 ANGSTROMS REMARK 600 REMARK 600 HETEROGEN REMARK 600 THE INHIBITOR IS BOUND TO THE ACTIVE SITE OF THE ENZYME. THE REMARK 600 UNBOUND FORM OF THE INHIBITOR IS MCR-D-PHE-PRO-ARG- REMARK 600 CHLOROMETHYLKETONE. UPON REACTION WITH PROTEIN IT FORMS TWO REMARK 600 COVALENT BONDS: 1) A COVALENT BOND TO SER 195 FORMING A HEMIKETAL REMARK 600 AR7 AND 2) A COVALENT BOND TO NE2 OF HIS 57 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HG H1001 HG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 0ZJ F 299 S2 REMARK 620 2 ASP H 106 OD1 103.9 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HG D1004 HG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 0ZJ B 299 S2 REMARK 620 2 ASP D 106 OD2 93.0 REMARK 620 N 1 REMARK 630 REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: N-(SULFANYLACETYL)-D-PHENYLALANYL-N-[(2S,3S)-6-{ REMARK 630 [AMINO(IMINIO)METHYL]AMINO}-1-CHLORO-2-HYDROXYHEXAN-3-YL]-L- REMARK 630 PROLINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 0ZJ B 299 REMARK 630 0ZJ F 299 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: MCR DPN PRO AR7 0QE REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0ZJ B 299 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0ZJ F 299 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HG H 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HG H 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HG D 1003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HG D 1004 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD H 2000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD D 2001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD D 2003 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD H 2004 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1NU9 RELATED DB: PDB REMARK 900 STAPHYLOCOAGULASE-PRETHROMBIN-2 COMPLEX DBREF 1NU7 A 1D 14J UNP P00734 THRB_HUMAN 332 359 DBREF 1NU7 B 16 247 UNP P00734 THRB_HUMAN 364 622 DBREF 1NU7 D 1 281 UNP Q846V4 Q846V4_STAAU 1 281 DBREF 1NU7 E 1D 14J UNP P00734 THRB_HUMAN 332 359 DBREF 1NU7 F 16 247 UNP P00734 THRB_HUMAN 364 622 DBREF 1NU7 H 1 281 UNP Q846V4 Q846V4_STAAU 1 281 SEQADV 1NU7 MET D 0 UNP Q846V4 INITIATING METHIONINE SEQADV 1NU7 MET H 0 UNP Q846V4 INITIATING METHIONINE SEQRES 1 A 28 GLY GLU ALA ASP CYS GLY LEU ARG PRO LEU PHE GLU LYS SEQRES 2 A 28 LYS SER LEU GLU ASP LYS THR GLU ARG GLU LEU LEU GLU SEQRES 3 A 28 SER TYR SEQRES 1 B 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 B 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 B 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 B 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 B 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 B 259 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 B 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 B 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 B 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 B 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 B 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 B 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN SEQRES 13 B 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU SEQRES 14 B 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR SEQRES 15 B 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY SEQRES 16 B 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO SEQRES 17 B 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN SEQRES 18 B 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 B 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 B 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU SEQRES 1 D 282 MET ILE VAL THR LYS ASP TYR SER LYS GLU SER ARG VAL SEQRES 2 D 282 ASN GLU ASN SER LYS TYR GLY THR LEU ILE SER ASP TRP SEQRES 3 D 282 TYR LEU LYS GLY ARG LEU THR SER LEU GLU SER GLN PHE SEQRES 4 D 282 ILE ASN ALA LEU GLY ILE LEU GLU THR TYR HIS TYR GLY SEQRES 5 D 282 GLU LYS GLU TYR LYS ASP ALA LYS ASP LYS LEU MET THR SEQRES 6 D 282 ARG ILE LEU GLY GLU ASP GLN TYR LEU LEU GLU ARG LYS SEQRES 7 D 282 LYS VAL GLN TYR GLU GLU TYR LYS LYS LEU TYR LYS LYS SEQRES 8 D 282 TYR LYS GLU GLU ASN PRO THR SER LYS VAL LYS MET LYS SEQRES 9 D 282 THR PHE ASP GLN TYR THR ILE GLU ASP LEU THR MET ARG SEQRES 10 D 282 GLU TYR ASN GLU LEU THR GLU SER LEU LYS SER ALA VAL SEQRES 11 D 282 LYS ASP PHE GLU LYS ASP VAL GLU ILE ILE GLU ASN GLN SEQRES 12 D 282 HIS HIS ASP LEU LYS PRO PHE THR ASP GLU MET GLU GLU SEQRES 13 D 282 LYS ALA THR ALA ARG VAL ASP ASP LEU ALA ASN LYS ALA SEQRES 14 D 282 TYR SER VAL TYR PHE ALA PHE VAL ARG ASP THR GLN HIS SEQRES 15 D 282 LYS THR GLU ALA LEU GLU LEU LYS ALA LYS VAL ASP LEU SEQRES 16 D 282 VAL LEU GLY ASP GLU ASP LYS PRO HIS ARG ILE SER ASN SEQRES 17 D 282 GLU ARG ILE GLU LYS GLU MET ILE LYS ASP LEU GLU SER SEQRES 18 D 282 ILE ILE GLU ASP PHE PHE ILE GLU THR GLY LEU ASN LYS SEQRES 19 D 282 PRO ASP ASN ILE THR SER TYR ASP SER SER LYS HIS HIS SEQRES 20 D 282 TYR LYS ASN HIS SER GLU GLY PHE GLU ALA LEU VAL LYS SEQRES 21 D 282 GLU THR ARG GLU ALA VAL THR ASN ALA ASN ASP SER TRP SEQRES 22 D 282 LYS THR LYS THR VAL LYS LYS TYR GLY SEQRES 1 E 28 GLY GLU ALA ASP CYS GLY LEU ARG PRO LEU PHE GLU LYS SEQRES 2 E 28 LYS SER LEU GLU ASP LYS THR GLU ARG GLU LEU LEU GLU SEQRES 3 E 28 SER TYR SEQRES 1 F 259 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 F 259 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 F 259 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 F 259 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 F 259 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 F 259 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 F 259 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 F 259 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 F 259 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 F 259 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 F 259 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 F 259 LEU LYS GLU THR TRP THR ALA ASN VAL GLY LYS GLY GLN SEQRES 13 F 259 PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE VAL GLU SEQRES 14 F 259 ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG ILE THR SEQRES 15 F 259 ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP GLU GLY SEQRES 16 F 259 LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY GLY PRO SEQRES 17 F 259 PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP TYR GLN SEQRES 18 F 259 MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP ARG ASP SEQRES 19 F 259 GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG LEU LYS SEQRES 20 F 259 LYS TRP ILE GLN LYS VAL ILE ASP GLN PHE GLY GLU SEQRES 1 H 282 MET ILE VAL THR LYS ASP TYR SER LYS GLU SER ARG VAL SEQRES 2 H 282 ASN GLU ASN SER LYS TYR GLY THR LEU ILE SER ASP TRP SEQRES 3 H 282 TYR LEU LYS GLY ARG LEU THR SER LEU GLU SER GLN PHE SEQRES 4 H 282 ILE ASN ALA LEU GLY ILE LEU GLU THR TYR HIS TYR GLY SEQRES 5 H 282 GLU LYS GLU TYR LYS ASP ALA LYS ASP LYS LEU MET THR SEQRES 6 H 282 ARG ILE LEU GLY GLU ASP GLN TYR LEU LEU GLU ARG LYS SEQRES 7 H 282 LYS VAL GLN TYR GLU GLU TYR LYS LYS LEU TYR LYS LYS SEQRES 8 H 282 TYR LYS GLU GLU ASN PRO THR SER LYS VAL LYS MET LYS SEQRES 9 H 282 THR PHE ASP GLN TYR THR ILE GLU ASP LEU THR MET ARG SEQRES 10 H 282 GLU TYR ASN GLU LEU THR GLU SER LEU LYS SER ALA VAL SEQRES 11 H 282 LYS ASP PHE GLU LYS ASP VAL GLU ILE ILE GLU ASN GLN SEQRES 12 H 282 HIS HIS ASP LEU LYS PRO PHE THR ASP GLU MET GLU GLU SEQRES 13 H 282 LYS ALA THR ALA ARG VAL ASP ASP LEU ALA ASN LYS ALA SEQRES 14 H 282 TYR SER VAL TYR PHE ALA PHE VAL ARG ASP THR GLN HIS SEQRES 15 H 282 LYS THR GLU ALA LEU GLU LEU LYS ALA LYS VAL ASP LEU SEQRES 16 H 282 VAL LEU GLY ASP GLU ASP LYS PRO HIS ARG ILE SER ASN SEQRES 17 H 282 GLU ARG ILE GLU LYS GLU MET ILE LYS ASP LEU GLU SER SEQRES 18 H 282 ILE ILE GLU ASP PHE PHE ILE GLU THR GLY LEU ASN LYS SEQRES 19 H 282 PRO ASP ASN ILE THR SER TYR ASP SER SER LYS HIS HIS SEQRES 20 H 282 TYR LYS ASN HIS SER GLU GLY PHE GLU ALA LEU VAL LYS SEQRES 21 H 282 GLU THR ARG GLU ALA VAL THR ASN ALA ASN ASP SER TRP SEQRES 22 H 282 LYS THR LYS THR VAL LYS LYS TYR GLY HET 0ZJ B 299 34 HET HG D1003 1 HET HG D1004 1 HET IMD D2001 5 HET IMD D2003 5 HET IMD D2005 5 HET 0ZJ F 299 34 HET HG H1001 1 HET HG H1002 1 HET IMD H2000 5 HET IMD H2002 5 HET IMD H2004 5 HETNAM 0ZJ N-(SULFANYLACETYL)-D-PHENYLALANYL-N-[(2S,3S)-6- HETNAM 2 0ZJ {[AMINO(IMINIO)METHYL]AMINO}-1-CHLORO-2-HYDROXYHEXAN- HETNAM 3 0ZJ 3-YL]-L-PROLINAMIDE HETNAM HG MERCURY (II) ION HETNAM IMD IMIDAZOLE HETSYN 0ZJ ATA-FPR-CH2CL, ATA-PPACK FORMUL 7 0ZJ 2(C23 H36 CL N6 O4 S 1+) FORMUL 8 HG 4(HG 2+) FORMUL 10 IMD 6(C3 H5 N2 1+) FORMUL 19 HOH *748(H2 O) HELIX 1 1 PHE A 7 SER A 11 5 5 HELIX 2 2 THR A 14B TYR A 14J 1 9 HELIX 3 3 ALA B 55 CYS B 58 5 4 HELIX 4 4 PRO B 60B ASP B 60E 5 4 HELIX 5 5 THR B 60I ASN B 62 5 3 HELIX 6 6 ASP B 125 LEU B 130 1 9 HELIX 7 7 THR B 149 GLY B 149D 5 5 HELIX 8 8 GLU B 164 THR B 172 1 9 HELIX 9 9 LYS B 185 GLY B 186C 5 5 HELIX 10 10 LEU B 234 PHE B 245 1 12 HELIX 11 11 ASN D 15 GLY D 19 5 5 HELIX 12 12 SER D 23 THR D 47 1 25 HELIX 13 13 TYR D 48 GLY D 51 5 4 HELIX 14 14 GLU D 52 GLU D 54 5 3 HELIX 15 15 TYR D 55 ASN D 95 1 41 HELIX 16 16 THR D 114 HIS D 143 1 30 HELIX 17 17 HIS D 144 LYS D 147 5 4 HELIX 18 18 THR D 150 VAL D 176 1 27 HELIX 19 19 HIS D 181 GLY D 197 1 17 HELIX 20 20 ASN D 207 GLY D 230 1 24 HELIX 21 21 ASP D 241 HIS D 246 1 6 HELIX 22 22 HIS D 250 ALA D 268 1 19 HELIX 23 23 ASP D 270 THR D 276 5 7 HELIX 24 24 PHE E 7 SER E 11 5 5 HELIX 25 25 THR E 14B SER E 14I 1 8 HELIX 26 26 ALA F 55 CYS F 58 5 4 HELIX 27 27 PRO F 60B ASP F 60E 5 4 HELIX 28 28 THR F 60I ASN F 62 5 3 HELIX 29 29 ASP F 125 LEU F 130 1 9 HELIX 30 30 THR F 149 GLY F 149D 5 5 HELIX 31 31 GLU F 164 SER F 171 1 8 HELIX 32 32 LYS F 185 GLY F 186C 5 5 HELIX 33 33 LEU F 234 GLY F 246 1 13 HELIX 34 34 ASN H 15 GLY H 19 5 5 HELIX 35 35 SER H 23 GLU H 46 1 24 HELIX 36 36 THR H 47 GLY H 51 5 5 HELIX 37 37 GLU H 52 GLU H 54 5 3 HELIX 38 38 TYR H 55 ASN H 95 1 41 HELIX 39 39 THR H 114 HIS H 143 1 30 HELIX 40 40 HIS H 144 LYS H 147 5 4 HELIX 41 41 THR H 150 VAL H 176 1 27 HELIX 42 42 HIS H 181 LEU H 196 1 16 HELIX 43 43 ASN H 207 GLY H 230 1 24 HELIX 44 44 ASP H 241 HIS H 246 1 6 HELIX 45 45 HIS H 250 ALA H 268 1 19 HELIX 46 46 ASP H 270 THR H 276 5 7 SHEET 1 A 7 SER B 20 ASP B 21 0 SHEET 2 A 7 GLN B 156 PRO B 161 -1 O VAL B 157 N SER B 20 SHEET 3 A 7 LYS B 135 GLY B 140 -1 N GLY B 136 O LEU B 160 SHEET 4 A 7 PRO B 198 LYS B 202 -1 O VAL B 200 N ARG B 137 SHEET 5 A 7 TRP B 207 TRP B 215 -1 O TYR B 208 N MET B 201 SHEET 6 A 7 GLY B 226 HIS B 230 -1 O PHE B 227 N TRP B 215 SHEET 7 A 7 MET B 180 ALA B 183 -1 N PHE B 181 O TYR B 228 SHEET 1 B 7 GLN B 30 ARG B 35 0 SHEET 2 B 7 GLU B 39 LEU B 46 -1 O GLU B 39 N ARG B 35 SHEET 3 B 7 TRP B 51 THR B 54 -1 O LEU B 53 N SER B 45 SHEET 4 B 7 ALA B 104 LEU B 108 -1 O MET B 106 N VAL B 52 SHEET 5 B 7 LYS B 81 ILE B 90 -1 N TYR B 89 O LEU B 105 SHEET 6 B 7 LEU B 64 ILE B 68 -1 N ILE B 68 O LYS B 81 SHEET 7 B 7 GLN B 30 ARG B 35 -1 N PHE B 34 O LEU B 65 SHEET 1 D 7 SER F 20 ASP F 21 0 SHEET 2 D 7 GLN F 156 PRO F 161 -1 O VAL F 157 N SER F 20 SHEET 3 D 7 LYS F 135 GLY F 140 -1 N GLY F 136 O LEU F 160 SHEET 4 D 7 PRO F 198 LYS F 202 -1 O VAL F 200 N ARG F 137 SHEET 5 D 7 TRP F 207 TRP F 215 -1 O TYR F 208 N MET F 201 SHEET 6 D 7 GLY F 226 HIS F 230 -1 O PHE F 227 N TRP F 215 SHEET 7 D 7 MET F 180 ALA F 183 -1 N PHE F 181 O TYR F 228 SHEET 1 E 7 LYS F 81 SER F 83 0 SHEET 2 E 7 LEU F 64 ILE F 68 -1 N ILE F 68 O LYS F 81 SHEET 3 E 7 GLN F 30 ARG F 35 -1 N MET F 32 O ARG F 67 SHEET 4 E 7 GLU F 39 LEU F 46 -1 O CYS F 42 N LEU F 33 SHEET 5 E 7 TRP F 51 THR F 54 -1 O LEU F 53 N SER F 45 SHEET 6 E 7 ALA F 104 LEU F 108 -1 O ALA F 104 N THR F 54 SHEET 7 E 7 LEU F 85 ILE F 90 -1 N TYR F 89 O LEU F 105 SHEET 1 G 2 GLY H 197 ASP H 198 0 SHEET 2 G 2 LYS H 201 PRO H 202 -1 O LYS H 201 N ASP H 198 SSBOND 1 CYS A 1 CYS B 122 1555 1555 2.06 SSBOND 2 CYS B 42 CYS B 58 1555 1555 2.06 SSBOND 3 CYS B 168 CYS B 182 1555 1555 2.04 SSBOND 4 CYS B 191 CYS B 220 1555 1555 2.05 SSBOND 5 CYS E 1 CYS F 122 1555 1555 2.06 SSBOND 6 CYS F 42 CYS F 58 1555 1555 2.05 SSBOND 7 CYS F 168 CYS F 182 1555 1555 2.04 SSBOND 8 CYS F 191 CYS F 220 1555 1555 2.05 LINK OG SER B 195 C4 0ZJ B 299 1555 1555 1.38 LINK OG SER F 195 C4 0ZJ F 299 1555 1555 1.39 LINK NE2 HIS B 57 CM 0ZJ B 299 1555 1555 1.44 LINK NE2 HIS F 57 CM 0ZJ F 299 1555 1555 1.45 LINK S2 0ZJ B 299 HG HG D1003 1555 1555 2.37 LINK S2 0ZJ F 299 HG HG H1001 1555 1555 2.40 LINK S2 0ZJ B 299 HG HG D1004 1555 1555 2.51 LINK S2 0ZJ F 299 HG HG H1002 1555 1555 2.67 LINK OD2 ASP D 106 HG HG D1004 1555 1555 2.88 LINK OD1 ASP H 106 HG HG H1001 1555 1555 3.05 CISPEP 1 SER B 36A PRO B 37 0 -1.04 CISPEP 2 SER F 36A PRO F 37 0 -0.60 SITE 1 AC1 16 HIS B 57 TRP B 60D LEU B 99 ASP B 189 SITE 2 AC1 16 ALA B 190 GLY B 193 SER B 195 SER B 214 SITE 3 AC1 16 TRP B 215 GLY B 216 GLY B 219 GLY B 226 SITE 4 AC1 16 HOH B 313 HOH B 462 HG D1003 HG D1004 SITE 1 AC2 17 HIS F 57 TRP F 60D LEU F 99 ILE F 174 SITE 2 AC2 17 ASP F 189 ALA F 190 GLU F 192 GLY F 193 SITE 3 AC2 17 SER F 195 SER F 214 TRP F 215 GLY F 216 SITE 4 AC2 17 GLY F 219 GLY F 226 HOH F 290 HG H1001 SITE 5 AC2 17 HG H1002 SITE 1 AC3 3 0ZJ F 299 ASP H 106 HG H1002 SITE 1 AC4 3 0ZJ F 299 ASP H 106 HG H1001 SITE 1 AC5 3 0ZJ B 299 ASP D 106 HG D1004 SITE 1 AC6 3 0ZJ B 299 ASP D 106 HG D1003 SITE 1 AC7 3 TRP D 25 TYR H 84 LYS H 103 SITE 1 AC8 2 TYR D 84 LYS D 103 SITE 1 AC9 5 GLU D 219 LYS D 233 PRO D 234 ASP D 235 SITE 2 AC9 5 HOH D2175 SITE 1 BC1 3 GLU H 219 LYS H 233 PRO H 234 CRYST1 180.170 102.000 135.300 90.00 130.08 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005550 0.000000 0.004670 0.00000 SCALE2 0.000000 0.009804 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009660 0.00000